Literature DB >> 2539000

The choice of treatment after incomplete adenomectomy in acromegaly: proton--versus high voltage radiation.

D K Lüdecke1, B S Lutz, G Niedworok.   

Abstract

The authors report the results of a study designed to compare the effectiveness of two different types of radiation in patients with acromegaly where surgical therapy had failed to normalize growth hormone (GH). Longterm follow-up after conventional high voltage radiation in 17 patients and proton therapy in 13 patients confirmed a similar reduction of GH levels in both groups. After 4.5 years a decrease of about 80% was achieved. After "conventional radiation" GH was normal in 8 (47%) and near normal in 6 (35%) while proton therapy resulted in normalization in 5 and improvement in 5 (38%). The slightly better results of "conventional radiation" must be attributed to lower pretreatment levels of GH. Side effects as additional pituitary deficits and oculomotor palsies were more often seen after proton treatment. Since the results of both radiation methods are similar and proton therapy has a tendency to more serious side effects we recommend "conventional radiation" as secondary treatment of acromegaly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539000     DOI: 10.1007/bf01403492

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  18 in total

1.  [Excision of pituitary adenomas by trans-sphenoidal approach].

Authors:  J HARDY
Journal:  Union Med Can       Date:  1962-09

2.  Hypopituitarism following radiation therapy of pituitary adenomas.

Authors:  P J Snyder; B F Fowble; N J Schatz; P J Savino; T A Gennarelli
Journal:  Am J Med       Date:  1986-09       Impact factor: 4.965

3.  Conventional radiation therapy in acromegaly. A review and reassessment.

Authors:  A M Lawrence; S M Pinsky; I D Goldfine
Journal:  Arch Intern Med       Date:  1971-09

4.  [Comparison of various treatments for tumoral acromegaly. Study of initial prognostic factors].

Authors:  J Bringer; D Klawatsch; C Jaffiol; A Orsetti; M Robin; J Mirouze
Journal:  Ann Endocrinol (Paris)       Date:  1983 Mar-Apr       Impact factor: 2.478

5.  Recent developments in the treatment of acromegaly.

Authors:  D K Lüdecke
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

6.  The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.

Authors:  S W Lamberts; R Oosterom; M Neufeld; E del Pozo
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

7.  Acromegaly: analysis of 132 cases treated surgically.

Authors:  S Balagura; P Derome; G Guiot
Journal:  Neurosurgery       Date:  1981-04       Impact factor: 4.654

8.  Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients.

Authors:  H J Quabbe
Journal:  Clin Endocrinol (Oxf)       Date:  1982-02       Impact factor: 3.478

9.  Conventional supervoltage irradiation is an effective treatment for acromegaly.

Authors:  R C Eastman; P Gorden; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

10.  Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation.

Authors:  S Werner; E af Trampe; P Palacios; I Lax; K Hall
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-09       Impact factor: 7.038

View more
  2 in total

Review 1.  Reevaluation of conventional pituitary irradiation in the therapy of acromegaly.

Authors:  C A Jaffe
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child.

Authors:  J Flitsch; D K Lüdecke; N Stahnke; J Wiebel; W Saeger
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.